Congestive heart failure in patients treated with doxorubicin-Reference-Cited by-同舟云学术

Congestive heart failure in patients treated with doxorubicin

Published:2003-05-19 Issue:11 Volume:97 Page:2869-2879
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Swain Sandra M.,Whaley Fredrick S.,Ewer Michael S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

2. Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

3. Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapy.

4. The Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels, 9th ed. Boston: Little, Brown & Co, 1994: 253-256.

Cited by 1765 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guarding the heart: How SGLT-2 inhibitors protect against chemotherapy-induced cardiotoxicity;Current Problems in Cardiology;2024-03

2. Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity;Journal of Controlled Release;2024-02

3. Echocardiography versus Cardiac MRI for Measurement of Left Ventricular Ejection Fraction in Individuals with Cancer and Suspected Cardiotoxicity;Radiology: Cardiothoracic Imaging;2024-02-01

4. Doxorubicin-induced cardiotoxicity and risk factors;IJC Heart & Vasculature;2024-02

5. The Risk of Cancer-Associated and Radiotherapy-Associated Cardiovascular Diseases among Patients with Breast Cancer;Clinical Breast Cancer;2024-02